Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-18-012256)

Filing Details

Accession Number:: 0001225208-18-012256
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-03 15:38:33
Reporting Period:: 2018-08-01

Accepted Time:: 2018-08-03 15:38:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1745691	Michael Goettler	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Group President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-08-01	1,600	$39.72	29,522	No	4	S	Direct
Common Stock	Disposition	2018-08-01	3,300	$39.70	26,222	No	4	S	Direct
Common Stock	Disposition	2018-08-01	3,340	$39.71	22,882	No	4	S	Direct
Common Stock	Disposition	2018-08-01	10,958	$39.69	11,924	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Phantom Stock Units	Acquisiton	2018-08-01	17,383	$40.27	17,383	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,383			No	4	I	Direct

Footnotes

Each unit represents one phantom share of common stock.
The units, held under the Deferred Compensation Plan are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.